“Clinical Efficacy of the Human Tyrosinase Inhibitor Thiamidol (isobutylamido thiazolyl resorcinol) in Melasma” (2025) SKIN The Journal of Cutaneous Medicine, 9(2), p. s544. doi:10.25251/skin.10.supp.544.